According to a meta-analysis published in Nature Human Behaviour, the widespread use of digital technology may be associated with lower rates of cognitive decline in people over the age of 50. The results of the study — which analysed 57 studies involving more than 400,000 people with an average age of 69 — seem to contradict the hypothesis that the daily use of technology weakens cognitive ability.
Research has analyzed how extreme heat influences the biological age of elderly populations, specifically in the United States. The study, published in Science Advances, used blood samples from more than 3,600 adults with an average age of 68 collected between 2010 and 2016. The team compared epigenetic aging trends with the number of days of extreme heat in the participants' places of residence. The models showed that more days of heat or long-term heat — over a period of one to six years — increased the biological age of the participants by more than two years.
An international team has analyzed data from nearly half a million people to analyze the influence of genes or environment on mortality, age-related diseases and aging. Although the relationship may vary according to the type of disease, their conclusions are that the environment -especially socioeconomic conditions, smoking habits and physical exercise- has a much greater influence than genetics in all the aspects studied. Among other data, environment explains 17 % of the variation in mortality risk, while genetics is limited to 2 %. The results are published in the journal Nature Medicine.
From 2011 to 2019, improvements in life expectancy slowed down in many European countries and many experienced declines in this indicator during the Covid-19 pandemic (2019-2021), according to a study published in The Lancet Public Health. The research shows that the average annual improvement in life expectancy fell from 0.23 years (1990-2011) to 0.15 years (2011-2019) in 20 European countries, including Spain.
Researchers in China have analysed data from more than 4,500 people and identified 13 proteins linked to brain ageing. In addition, changes in protein concentrations in the blood tend to peak at ages 57, 70 and 78. According to the authors, who publish the results in the journal Nature Aging, these ages may reflect transitions in human brain health at specific ages, and could therefore be important for designing possible interventions in the brain ageing process.
The increase in human life expectancy may be slowing down, according to an analysis of data from nine regions around the world, including Spain, over the past three decades published today in Nature Aging. The accelerated rates of increase in life expectancy observed in the 20th century have slowed, especially after 2010: children born in recent years have a relatively low probability of reaching 100 years of age. The authors suggest that there is no evidence that a radical extension of life expectancy has occurred or will occur in the 21st century.
A modelling study published in The Lancet Public Health using data from 854 European cities estimates that heat-related deaths will triple in Europe by 2100 under current climate policies. A slight decrease in cold-related deaths is projected, while heat-related deaths will increase in all parts of Europe. The most affected areas will include Spain, Italy, Greece and parts of France. Currently, around eight times as many people in Europe die from cold as from heat, but this proportion is projected to decrease considerably by the end of the century.
Eating a vegan diet for eight weeks is associated with reductions in biological age estimates based on levels of DNA methylation, a type of chemical modification of DNA that alters the expression of genes, but not the DNA itself. This is the main conclusion of a study published in BMC Medicine in which 21 pairs of twins participated in a clinical trial. Of each pair, one person followed an omnivorous diet and the other a vegan - and lower calorie - diet during that period.
An international group of researchers has shown in mice that inhibiting an inflammatory protein called interleukin 11 improved the animals' metabolic status, health and frailty. In addition, it increased their life expectancy by an average of around 25%. These effects have not been tested in humans, but clinical trials are underway testing an antibody directed against the same protein to see if it benefits cystic fibrosis patients. The results of the new research are published in the journal Nature.
People who take multivitamins daily do not have a lower risk of mortality than people who do not use these products, according to a meta-analysis published in JAMA Network Open. The study pooled data from more than 390,000 people, followed for about 20 years in three different cohorts in the United States.